Browsing by Contributors Palmieri, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 6 of 6
PreviewIssue DateTitleContributor(s)
7-Jun-2016Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerEccles, SA; Aboagye, EO; Ali, S; Anderson, AS; Armes, J; Berditchevski, F; Blaydes, JP; Brennan, K; Brown, NJ; Bryant, HE; Bundred, NJ; Burchell, JM; Campbell, AM; Carroll, JS; Clarke, RB; Coles, CE; Cook, GJR; Cox, A; Curtin, NJ; Dekker, LV; Dos Santos Silva, I; Duffy, SW; Easton, DF; Eccles, DM; Edwards, DR; Edwards, J; Evans, D; Fenlon, DF; Flanagan, JM; Foster, C; Gallagher, WM; Garcia-Closas, M; Gee, JMW; Gescher, AJ; Goh, V; Groves, AM; Harvey, AJ; Harvie, M; Hennessy, BT; Hiscox, S; Holen, I; Howell, SJ; Howell, A; Hubbard, G; Hulbert-Williams, N; Hunter, MS; Jasani, B; Jones, LJ; Key, TJ; Kirwan, CC; Kong, A; Kunkler, IH; Langdon, SP; Leach, MO; Mann, DJ; Marshall, JF; Martin, L; Martin, SG; Macdougall, JE; Miles, DW; Miller, WR; Morris, JR; Moss, SM; Mullan, P; Natrajan, R; O’Connor, JPB; O’Connor, R; Palmieri, C; Pharoah, PDP; Rakha, EA; Reed, E; Robinson, SP; Sahai, E; Saxton, JM; Schmid, P; Smalley, MJ; Speirs, V; Stein, R; Stingl, J; Streuli, CH; Tutt, ANJ; Velikova, G; Walker, RA; Watson, CJ; Williams, KJ; Young, LS; Thompson, AM
7-Jun-2016Differential oestrogen receptor binding is associated with clinical outcome in breast cancerRoss-Innes, CS; Stark, R; Teschendorff, AE; Holmes, KA; Ali, HR; Dunning, MJ; Brown, GD; Gojis, O; Ellis, IO; Green, AR; Ali, S; Chin, S-F; Palmieri, C; Caldas, C; Carroll, JS
15-Apr-2016Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancerSaleem, A; Searle, GE; Kenny, LM; Huiban, M; Kozlowski, K; Waldman, AD; Woodley, L; Palmieri, C; Lowdell, C; Kaneko, T; Murphy, PS; Lau, MR; Aboagye, EO; Coombes, RC
29-Oct-2015Methylation of the calcium channel regulatory subunit alpha 2 delta-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomasPalmieri, C; Rudraraju, B; Monteverde, M; Lattanzio, L; Gojis, O; Brizio, R; Garrone, O; Merlano, M; Syed, N; Lo Nigro, C; Crook, T
3-Aug-2016Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancerPalmieri, C; Macpherson, IRJ; Yan, K; Ades, F; Riddle, P; Ahmed, R; Owadally, W; Stanley, B; Shah, D; Gojis, O; Januszewski, A; Lewanski, C; Asher, R; Lythgoe, D; De Azambuja, E; Beresford, M; Howell, SJ
29-Oct-2015NT5E CpG island methylation is a favourable breast cancer biomarkerLo Nigro, C; Monteverde, M; Lee, S; Lattanzio, L; Vivenza, D; Comino, A; Syed, N; McHugh, A; Wang, H; Proby, C; Garrone, O; Merlano, M; Hatzimichael, E; Briasoulis, E; Gojis, O; Palmieri, C; Jordan, L; Quinlan, P; Thompson, A; Crook, T